The Pattern of Fatty Acids Displaced by EPA and DHA Following 12 Months Supplementation Varies between Blood Cell and Plasma Fractions

Other literature type, Article English OPEN
Walker, Celia; West, Annette; Browning, Lucy; Madden, Jackie; Gambell, Joanna; Jebb, Susan; Calder, Philip;
  • Publisher: MDPI AG
  • Journal: Nutrients,volume 7,issue 8,pages6,281-6,293 (issn: 2072-6643, eissn: 2072-6643)
  • Publisher copyright policies & self-archiving
  • Related identifiers: doi: 10.3390/nu7085285, pmc: PMC4555124
  • Subject: Nutrition. Foods and food supply | plasma fatty acid fractions | TX341-641 | n-6 fatty acid | fatty acid displacement | EPA and DHA supplementation | n-3 fatty acid | Article | blood cell fatty acids
    mesheuropmc: lipids (amino acids, peptides, and proteins)

Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are increased in plasma lipids and blood cell membranes in response to supplementation. Whilst arachidonic acid (AA) is correspondingly decreased, the effect on other fatty acids (FA) is less well described and ... View more
  • References (21)
    21 references, page 1 of 3

    1. Deckelbaum, R.; Torrejon, C. The omega-3 fatty acid nutritional landscape: Health benefits and sources. J. Nutr. 2012, 142, 587S-591S. [CrossRef] [PubMed]

    2. Saravanan, P.; Davidson, N.C.; Schmidt, E.B.; Calder, P.C. Cardiovascular effects of marine omega-3 fatty acids. Lancet 2010, 376, 540-550. [CrossRef]

    3. Calder, P.C. Very long chain omega-3 (n-3) fatty acids and human health. Eur. J. Lipid Sci. Technol. 2014, 116, 1280-1300. [CrossRef]

    4. Hoy, S.; Keating, G. Omega-3 ethylester concentrate. Drugs 2009, 69, 1077-1105. [CrossRef] [PubMed]

    5. Bradberry, J.C.; Hilleman, D.E. Overview of omega-3 fatty acid therapies. P T. 2013, 38, 681-691. [PubMed]

    6. Yates, C.M.; Calder, P.C.; Ed Rainger, G. Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease. P T. 2014, 141, 272-282. [CrossRef] [PubMed]

    7. Calder, P.C. Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance. Biochim. Biophys. Acta 2015, 1851, 469-484. [CrossRef] [PubMed]

    8. Arterburn, L.M.; Hall, E.B.; Oken, H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am. J. Clin. Nutr. 2006, 83, S1467-1476S.

    9. Lovegrove, J.A.; Lovegrove, S.S.; Lesauvage, S.V.; Brady, L.M.; Saini, N.; Minihane, A.M.; Williams, C.M. Moderate fish-oil supplementation reverses low-platelet, long-chain n-3 polyunsaturated fatty acid status and reduces plasma triacylglycerol concentrations in British Indo-Asians. Am. J. Clin. Nutr. 2004, 79, 974-982. [PubMed]

    10. Krul, E.S.; Lemke, S.L.; Mukherjea, R.; Taylor, M.L.; Goldstein, D.A.; Su, H.; Liu, P.; Lawless, A.; Harris, W.S.; Maki, K.C. Effects of duration of treatment and dosage of eicosapentaenoic acid and stearidonic acid on red blood cell eicosapentaenoic acid content. Prostaglandins Leukot. Essent. Fatty Acids 2012, 86, 51-59. [CrossRef] [PubMed]

  • Related Organizations (8)
  • Metrics
Share - Bookmark